In conclusion, our current study provides the first evidence that DDX21 protein was upregulated in HCC tissues compared with paracancerous tissues and that elevated levels of DDX21 protein were obtained in recurrent HCC patients compared with nonrecurrent cases. Here, DDX21 is linked to hepatocellular carcinoma.